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Anthranoid laxatives, belonging to the anthraquinones as do anthracyclines, possibly increase colorectal cancer risk.
Anthracyclines interfere with topoisomerase II, intercalate DNA and are substrates for P-glycoprotein and multidrug resistance-
associated protein 1. P-glycoprotein and multidrug resistance-associated protein 1 protect colonic epithelial cells against
xenobiotics. The aim of this study was to analyse the interference of anthranoids with these natural defence mechanisms and
the direct cytotoxicity of anthranoids in cancer cell lines expressing these mechanisms in varying combinations. A cytotoxicity
proﬁle of rhein, aloe emodin and danthron was established in related cell lines exhibiting different levels of topoisomerases,
multidrug resistance-associated protein 1 and P-glycoprotein. Interaction of rhein with multidrug resistance-associated protein
1 was studied by carboxy ﬂuorescein efﬂux and direct cytotoxicity by apoptosis induction. Rhein was less cytotoxic in the
multidrug resistance-associated protein 1 overexpressing GLC4/ADR cell line compared to GLC4. Multidrug resistance-
associated protein 1 inhibition with MK571 increased rhein cytotoxicity. Carboxy ﬂuorescein efﬂux was blocked by rhein. No
P-glycoprotein dependent rhein efﬂux was observed, nor was topoisomerase II responsible for reduced toxicity. Rhein induced
apoptosis but did not intercalate DNA. Aloe emodin and danthron were no substrates for MDR mechanisms. Rhein is a
substrate for multidrug resistance-associated protein 1 and induces apoptosis. It could therefore render the colonic epithelium
sensitive to cytotoxic agents, apart from being toxic in itself.
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Anthranoids are a group of substances with laxative action, includ-
ing, amongst others, sennosides with their active metabolites rhein
and rhein anthrone, aloe emodin and the synthetically produced
danthron. Especially sennosides are commonly used as self-medica-
tion for constipation and chronic use of these laxatives has been
associated with the development of pseudomelanosis coli (Steer
and Colin-Jones, 1975). This condition is characterised by a
brownish pigmentation of the colonic mucosa and is mostly
regarded as a harmless phenomenon. Pseudomelanosis coli however,
has been associated with an increased risk of colorectal cancer
(Siegers et al, 1993). In addition, a single high-dose of sennosides
was shown to induce an increase in proliferative activity of colonic
epithelial cells (Kleibeuker et al, 1995), which is generally consid-
ered to be one of the ﬁrst steps in colorectal carcinogenesis
(Preston-Martin et al, 1990). Furthermore, several in vitro and
animal studies have demonstrated mutagenic (Westendorf et al,
1990), genotoxic (Westendorf et al, 1990; Brown, 1980) and carci-
nogenic (Mori et al, 1985) effects of different anthranoid laxatives.
Anthranoid laxatives belong to the anthraquinones (Figure 1), a
group of chemicals which also includes the cytotoxic anthracyclines
used in cancer treatment. Anthracyclines exert their cytotoxicity by
inhibition of topoisomerase II, intercalation of DNA and formation
of free radicals (Stewart and Ratain, 2001). Thus leading to DNA
damage and ﬁnally to induction of (apoptotic) cell death (Gamen
et al, 1997). Repeated exposure of tumour cells to anthracyclines
can lead to resistance for both anthracyclines and other natural
product drugs with different chemical structure and mechanism
of action (Goldstein, 1996), a phenomenon which is called multi-
drug resistance (MDR). Mechanisms contributing to MDR for
anthracyclines include alterations in levels and/or activity of topoi-
somerase II (topo II) (Defﬁe et al, 1989) and increased expression
of the drug efﬂux pumps P-glycoprotein (P-gp) (Hu et al, 1995)
and of the glutathione dependent multidrug resistance-associated
protein1 (MRP1) (Breuninger et al, 1995). P-gp and MRP1 drug
efﬂux pumps are also expressed in normal colonic epithelium at
low to intermediate levels (Chaman et al, 1996). They are probably
involved in the protection of colonic epithelial cells against damage
induced by xenobiotics (Shen et al, 1996). As anthranoid laxatives
are also ‘natural products’ and chemically related to anthracyclines
they are likely to be substrates for MDR mechanisms. The toxicity
of anthranoid laxatives might, apart from their direct cytotoxic
activity, be related to the effect of the laxatives on the defence
mechanisms of the colonic epithelium making it more susceptible
to other toxic agents.
In the present study the interference of anthranoids with the
different mechanisms of MDR was studied in panels of related
tumour cell lines expressing these mechanisms in different ways.
In order to conﬁrm anthranoid cytotoxicity apoptosis induction
was studied in cell lines of different origin and DNA intercalation,
as a possible mechanism of action, was determined in plasmid
DNA.
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Chemicals
Rhein (9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecar-
boxylic acid), aloe emodin (1,8-Dihydroxyl-3-(hydroxymethyl)-
anthraquinone, danthron (1,8-Dihydroxyanthraquinone), MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide), DL-
buthionine-[S,R]-sulphoximine (BSO) and protease XXIV were
purchased from Sigma (St Louis, MO, USA). Roswell Park Memorial
Institute (RPMI) 1640 medium, foetal calf serum (FCS), Dulbecco’s
modiﬁed eagle (DME) and Ham’s F12 (HAM) media were obtained
from Life Technologies (Paisley, UK), dimethyl sulphoxide (DMSO)
and acridine orange from Merck (Darmstadt, Germany). Rhein, aloe
emodin and danthron were dissolved in DMSO. Doxorubicin was
purchased from Pharmacia UpJohn (Woerden, The Netherlands)
and vincristine sulphate-TEVA from Abic Ltd (Netanya, Israel).
Carboxy ﬂuorescein diacetate was obtained from Molecular Probes
(Leiden, The Netherlands). Agarose I for electrophoresis was
purchased from Amresco (Solom, Ohio) and ethidium bromide from
Serva (Heidelberg, Germany). Dr Ford-Hutchinson, Merck Sharp,
Canada kindly provided MK571.
Cell lines
Table 1 presents the cell lines used with their speciﬁc characteris-
tics, according to which they were selected for the experiments.
The ﬁrst panel consists of GLC4, GLC4/ADR, GLC4/VM, GLC4/
AMSA and GLC4/P-gp. GLC4 is a human small cell lung carcino-
ma cell line and, by ongoing incubation, GLC4/ADR is its at this
moment 345-fold in vitro acquired doxorubicin resistant subline.
Resistance in the GLC4/ADR is due to MRP1 overexpression and
to a reduced Topo II activity (Zaman et al, 1993; De Jong et al,
1991). GLC4/ADR is cultured with 1.2 mM doxorubicin twice
weekly. In the in vitro acquired 3-fold amsacrine-resistant subline
GLC4/AMSA and the 20-fold teniposide-resistant subline GLC4/
VM of GLC4, resistance is due to reduced Topo IIb and Topo
IIa expression respectively without overexpression of MRP1 or P-
gp (Withoff et al, 1996). The GLC4/P-gp subline has a 325-fold
resistance to vincristine compared to GLC4. GLC4/P-gp was
obtained after infection of GLC4 cells with an MDR1-gene-carrying
retrovirus (Hendrikse et al, 1999). GLC4/P-gp cells were cultured
twice weekly with 50 nM vincristine sulphate to retain the trans-
fected MDR1 gene.
The second panel of cell lines includes A2780, an ovarian carci-
noma cell line, and 2780/AD its 100-fold in vitro acquired
doxorubicin resistant P-gp overexpressing subline (Rogan et al,
1984). 2780/AD cells are cultured with 2.0 mM doxorubicin twice
weekly. In addition two unrelated cell lines representing extreme
inherent drug resistance and drug sensitivity, respectively, are
used: the Caco-2 cell line, derived from a colon carcinoma (Fogh
et al, 1977), and the N-Tera 2/D1 (Tera), an embryonal carcino-
ma cell line derived from a testicular tumour (Andrews et al,
1984).
All cell lines are routinely cultured in RPMI medium with 10%
FCS. For the cell lines cultured in the presence of drugs, cells were
cultured in drug-free medium for at least four passages before the
start of the experiments.
Screening of anthranoid laxatives by cytotoxicity proﬁle
The microculture tetrazolium (MTT) assay was used for determi-
nation of drug cytotoxicity as described earlier (Timmer-Bosscha
et al, 1989). In 96-well-plates (Nunc, Life Technologies, Paisley,
UK), in 0.1 ml medium consisting of 40% HAM’s F12, 40%
DME and 20% FCS different numbers of cells were used for each
cell line in order to assure linearity of the assay. For GLC4, GLC4/
AMSA, GLC4/VM and for Caco-2 (in 0.2 ml) 3750 cells, for GLC4/
ADR and GLC4/Pgp 10000 cells, for A27801250 cells, and for
2780/AD 5000 cells per well were incubated with increasing
concentrations of rhein, aloe emodin or danthron. Plates were kept
at 378C in a humidiﬁed atmosphere with 5% CO2. After 4 days
incubation, 20 ml of MTT solution (5 mg MTT ml
71 phosphate
buffered saline (PBS), (136 mM NaCl, 2.5 mM KCl, 6.5 mM
Na2HPO4.2H2O, 1.5 mM KH2PO4, pH 7.2) was added. After
3.75 h incubation the plates were centrifuged (15 min, 180 g),
supernatant was aspirated, 200 ml 100% DMSO added and extinc-
tion read at 520 nm (Timmer-Bosscha et al, 1989). The mean
concentration that caused 50% cell kill (IC50) was determined in
at least three independent experiments each performed in quadru-
plicate. The cytotoxicity assay with aloe emodin and danthron did
not discriminate between GLC4 and GLC4/ADR or between A2780
and 2780/AD. Therefore these drugs were not studied further in
the other cell lines.
The role of drug efﬂux mechanisms, modulation of
cytotoxicity
In the presence or absence of MRP1-inhibitor MK571 (50 mM)
rhein cytotoxicity was determined in GLC4 and GLC4/ADR. To
determine the glutathione-dependency of rhein cytotoxicity (Mu ¨ller
et al, 1994), GLC4 and GLC4/ADR cells were preincubated with the
glutathione synthesis inhibitor BSO, at a concentration of 25 mM
24 h before testing, which was shown before to reduce cellular
glutathione to levels below 0.1 mg glutathione mg
71 cellular
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Figure 1 Structural formulas of anthranoid laxatives and anthracycline.
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with doxorubicin to determine efﬁciency of BSO preincubation.
As glutathione synthesis is probably only inhibited as long as
BSO is present, experiments were repeated with 4 h incubation
of GLC4 and GLC4/ADR cells with rhein or doxorubicin, immedi-
ately following glutathione depletion. After 4 h, cells were washed
three times with medium, then incubated for 4 days and analysed
as described above.
The role of drug efﬂux mechanisms, ﬂow cytometric
detection of carboxy ﬂuorescein (CF) retention by rhein
Carboxy ﬂuorescein diacetate (CFDA) is a nonﬂuorescent
compound, which permeates the plasma membrane, and upon
cleavage of the ester bonds by intracellular esterases, it is trans-
formed into the ﬂuorescent anion CF, which is a speciﬁc
substrate for MRP1. The efﬂux of CF can be blocked speciﬁcally
by the MRP1-inhibitor MK571 (Van der Kolk et al, 1998). The
effect of rhein coincubation on cellular CF efﬂux was studied in
GLC4 and GLC4/ADR. Of each cell line 5610
5 cells were incu-
bated in RPMI medium for 20 min at 378C with CF 0.5 mM or
vehicle only, or combined with 15 mM or 60 mM rhein, or with
50 mM MK571 as a control. Cells were washed with ice-cold RPMI
medium and then resuspended in RPMI medium 378C without
CF but with rhein 15 or 60 mM or MK571 and kept for 1 h at
378C to allow for CF efﬂux or CF efﬂux-blocking. Efﬂux was
stopped by pelleting the cells and adding ice-cold RPMI medium.
Fluorescence of CF was analysed with a FAC-Star ﬂow cytometer
(Becton and Dickinson, Sunnyvale, CA, USA) equipped with an
argon laser. The CF ﬂuorescence of 10000 events was logarithmi-
cally measured at a laser excitation wavelength of 488 nm through
a 530 nm band-pass ﬁlter. The logarithmically acquired signals
were converted into linear values and expressed as relative ﬂuor-
escence units using the Winlist 2.0 program (Verity Software
House, Inc., Topsham, ME, USA). Results are expressed as CF
retention by the cells relative to the values found for CFDA plus
MK571 coincubation. All experiments were performed in tripli-
cate.
Direct cytotoxicity of anthranoid laxatives, induction of
apoptosis by rhein
To study the role of apoptosis susceptibility in anthranoid cyto-
toxicity, 10
6 cells of GLC4, GLC4/ADR, Caco-2 and Tera cell
lines were incubated with 100 mM rhein, and plated in PETRI
dishes (6 cm diameter) in RPMI 1640 medium with 10% FCS.
The GLC4 and GLC4/ADR were chosen because of different,
probably efﬂux related, rhein induced cytotoxicity. As controls
the Caco-2 a (colon) carcinoma cell line with a very low suscept-
ibility to drug-induced apoptosis and Tera (embryonal carcinoma
cell line) with a high propensity to go into apoptosis were used.
In the Caco-2 cell line MRP1, P-gp and MRP2 (Buchler et al,
1996) are expressed (Stephens et al, 2001). In the Tera cell line
no efﬂux pumps were detected (unpublished data). Besides,
Caco-2 has a deleted and Tera a wild type p53 genotype, which
may play a major role in their different drug sensitivities. After
6, 24, 48, 72 and 96 h acridine orange (1 mg ml
71) was added
to distinguish apoptotic from vital cells by ﬂuorescence micro-
scopy (Olympus IM) (Evans and Dive, 1993). All experiments
were performed in triplicate. Relative apoptosis induction was
calculated: the per cent apoptotic cells after incubation with
100 mM rhein at a certain time point is divided by the per cent
apoptotic cells in an untreated control sample at the same time
point.
Direct cytotoxicity of anthranoid laxatives, intercalation of
DNA
Intercalation of anthranoids as a possible mechanism of action
was studied by the unwinding of supercoiled plasmid DNA. Inter-
calation of a drug in supercoiled DNA leads to unwinding and
this can be visualised by a reduced migration of plasmid DNA
in an agarose gel (Hazlehurst et al, 1995). Supercoiled dimer of
plasmid PBR322 was prepared from Escherichia coli strain
HB101. Vials containing 3 ml PBR322, 9 ml tris-HCl-di-natrium-
EDTA (TE) and 10 ml rhein, or aloe emodin, danthron or doxor-
ubicin at different concentrations were incubated for 15 min at
378C, 2 ml loading buffer was added to each vial and samples were
put on a 1% agarose gel in tris-HCl-boric-acid-di-natrium-EDTA
(TBE). Samples were run for 20 h at 20 V and stained afterwards
with ethidium bromide (0.5 mgm l
71). DNA bands were visua-
lised by transillumination with UV and photographed using the
Imagemaster with Fuji Thermal ﬁlm (Pharmacia Biotech, Roosen-
daal, The Netherlands). All experiments were performed at least in
triplicate.
Statistical analysis
The paired Student’s t-test was used for statistical analysis. Only P-
values 50.05 were considered signiﬁcant.
RESULTS
Screening of anthranoid laxatives by cytotoxicity proﬁle
The MTT assay was performed with three anthranoid laxatives in
the GLC4, GLC4/ADR, A2780 and 2780/AD cells. For aloe emodin
or danthron no difference in cytotoxicity was observed between
GLC4 and GLC4/ADR or between A2780 and 2780/AD. Rhein
however, was more toxic for the GLC4 than for GLC4/ADR and
less toxic for the A2780 than for its doxorubicin-resistant subline
2780/AD (Table 2).
Resistance for rhein in GLC4/ADR can be related to either Topo
IIa and/or b reduction or MRP1 overexpression. To investigate
which of these mechanisms was most likely responsible for resis-
tance to rhein, cytotoxicity of rhein was determined in the
amsacrine resistant GLC4/AMSA and the teniposide resistant
GLC4/VM, with resistance solely due to reduction of Topo IIb
and Topo IIa respectively. Cytotoxicity of rhein was the same in
GLC4, GLC4/AMSA, and GLC4/VM (Table 2).
No difference in cytotoxicity of rhein could be demonstrated
between GLC4 and the MDR1-transfected subline GLC4/P-gp
(Table 2), whereas a distinct difference was seen in the cytotoxicity
of vincristine (0.9+0.2 and 283.2
*+45.1 respectively,
*P50.002).
To deﬁne Caco-2, one of the control cell lines in apoptosis induc-
tion, it was incubated with rhein in the MTT assay. The rhein IC50
was 64.3+11.6 mM (mean+s.e.m.) which is comparable to GLC4/
ADR.
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Table 1 Characteristics of different cell lines used in the experiments
Relative
doxorubicin- MDR-related mechanism P53
resistance involved in resistance status
GLC4 1 Mutant
GLC4/ADR
a 345 MRP1 : Topo IIa; Topo IIb; Mutant
GLC4/AMSA
a 5 Topo IIb; Mutant
GLC4/VM
a 8 Topo IIa; Mutant
GLC4/P-gp
a 12 P-gp : Mutant
A2780 1 Wild-type
2780/AD
b 100 P-gp : Wild-type
Caco-2
c MRP1 MRP2 P-gp Deletion
Tera Wild-type
aRelative to GLC4 (Withoff et al, 1996; Hendrikse et al, 1999), at the time of the
experiments.
bRelative to A2780 (Rogan et al, 1984).
cStephens et al, 2001.
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Blockage of the MRP1-pump by coincubation with MK571
increased rhein toxicity in GLC4/ADR to the same level as that
in GLC4 (Table 3, Figure 2). After preincubation with BSO,
followed by a 4 day, continuous, drug incubation there was no
difference in rhein cytotoxicity in GLC4 or GLC4/ADR (Table 3),
while doxorubicin cytotoxicity in GLC4/ADR increased (IC50
6.8+1.9 and 5.0+5.3 mM (mean+s.e.m.) in GLC4/ADR and
GLC4/ADR+BSO respectively, P50.01). Experiments were
repeated with 4 h drug incubation followed by a 4 day drug-free
culture. Doxorubicin cytotoxicity increased during the 4 h incuba-
tion in GLC4/ADR after preincubation with BSO (IC50 32.6+5.7
and 8.4+2.6 mM (mean+s.e.m.) in GLC4/ADR and GLC4/
ADR+BSO respectively, P50.01). However, due to poor solvability
of rhein, no discriminating cytotoxic effect of this drug could be
tested in this experiment.
The role of drug efﬂux mechanisms, ﬂow cytometric
detection of CF retention by rhein
To test whether rhein was also able to functionally affect the
MRP1 pump, GLC4 and GLC4/ADR cells were loaded with
the ﬂuorescent MRP1 substrate CF with and without 15 or
60 mM rhein or 50 mM MK571 and efﬂux was allowed for
1 h. In GLC4 and GLC4/ADR CF efﬂux was blocked in the
presence of MK571. To correct for inter-experimental ﬂuctua-
tions in the FACS analyses CF cell concentrations in the
presence of MK571 were deﬁned as 100% retention and served
as controls. Figure 3 shows the relative retention of CF after
incubation with rhein 15 mM or 60 mM compared to controls
in both GLC4 and GLC4/ADR. CF efﬂux was blocked by coin-
cubation with rhein at 60 mM in GLC4 (P50.05) and in GLC4/
ADR (P50.002). There was a trend for higher CF efﬂux, and
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Table 2 Cytotoxicity proﬁle of aloe emodin, danthron and rhein in the
panel of GLC4-cell lines, GLC4/ADR, GLC4/AMSA, GLC4/VM and GLC4/
P-gp and the panel of A2780 and 2780/AD cell lines as measured by MTT-
assay, expressed as relative sensitivity compared to the parent cell line
GLC4 and A2780 respectively (+s.e.m.)
Cell line Aloe emodin Danthron Rhein
GLC4 1.00+0.15
a 1.00+0.27
b 1.00+0.06
c
GLC4/ADR 1.26+0.16 1.06+0.27 1.61+0.10*
GLC4/AMSA ND ND 1.25+0.12
GLC4/VM ND ND 1.18+0.15
GLC4/P-gp ND ND 1.07+0.22
A2780 1.00+0.16
a 1.00+0.21
b 1.00+0.11
c
2780/AD 0.80+0.11 0.71+0.07 0.53+0.04
}
*P50.001 compared to GLC4.
}P50.05 compared to A2780. ND not done.
aIC50
GLC4: 23.4+3.6 mM;I C 50 A2780: 17.7+2.8 mM.
bIC50 GLC4: 23.1+6.2 mM;I C 50
A2780: 22.8+4.9 mM.
cIC50 GLC4: 41.4+2.5 mM;I C 50 A2780: 57.2+6.3 mM.
Table 3 Effect of MK571 and BSO preincubation on rhein cytotoxicity in
GLC4 and GLC4/ADR as measured by MTT-assay, expressed as relative
sensitivity compared to the parent cell line GCL4 (+s.e.m.)
Rhein+MK571 Rhein+BSO
Cell line Rhein coincubation coincubation
GLC4 1.00+0.09 0.99+0.18 0.91+0.14
GLC4/ADR 1.50+0.02
} 1.05+0.13
§ 1.54+0.21*
}P50.05 compared to GLC4.
§P50.05 compared to GLC4/ADR. *P50.05
compared to GLC4+BSO.
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Figure 3 Cellular retention of CF in GLC4 and GLC4/ADR at different
concentrations of rhein determined by ﬂow cytometry. Retention of CF in
GLC4 and GLC4/ADR in the presence of MK571 is deﬁned as 100% reten-
tion and served as controls. CF retention in the presence of 15 mM or
60 mM rhein is expressed as relative to controls. In GLC4 complete reten-
tion of CF could be achieved at 60 mM rhein. In GLC4/ADR 72% CF reten-
tion is accomplished (mean+s.e.m.). *P50.05 compared to CF in GLC4,
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GLC4 at 15 (P=0.16) and 60 mM rhein (P=0.21).
Direct cytotoxicity of anthranoid laxatives, induction of
apoptosis by rhein
Figure 4 shows the relative rhein induced apoptosis. Apoptosis
induction is found in the Tera cell line at 24 h and 96 h and a
trend for apoptosis induction is also seen at 6 h (P=0.053). In
the relative apoptosis resistant Caco-2 cell line at 48 h a signiﬁcant
induction of apoptosis is found. In GLC4/ADR after 96 h apoptosis
was found while in GLC4 no signiﬁcant induction was observed.
Direct cytotoxicity anthranoid laxatives, intercalation of
DNA
No intercalation of either rhein, aloe emodin or danthron could be
demonstrated at concentrations of 1, 10, 100 and 10000 mM,
whereas with doxorubicin a shift of plasmid DNA was already seen
at concentrations of 1 and 10 nM.
DISCUSSION
Chronic use of anthranoid laxatives, such as senna, is considered to
increase the risk of colorectal cancer (Siegers et al, 1993). In this
study two routes which could be involved in this increase are
studied, an effect of anthranoid laxatives on cellular efﬂux pumps
reducing the physiological defence mechanisms of the colon epithe-
lium and/or a direct cytotoxic effect of these agents on human
cells.
With the use of related cell line panels this study demonstrates
that the cytotoxicity proﬁle of the active anthranoid laxative meta-
bolite rhein is not homologue to that of doxorubicin in the panels
of cell lines chosen. In the P-gp overexpressing cell line 2780/AD,
the doxorubicin resistant subline of A2780, an increased sensitivity
of 2780/AD for rhein was observed. This seems not to be related
to increased expression of the P-gp drug efﬂux pump as in GLC4/
P-gp no increase in rhein cytotoxicity was found compared to
GLC4. Although the mechanism of this differential sensitivity of
A2780 and 2780/AD for rhein is unclear, one could speculate that
it could be due to the antimitochondrial activity of rhein (Verhae-
ren, 1980; Bironaite et al, 1992). Increased sensitivity to
mitochondrial inhibitors has been shown in another doxorubicin
resistant cell line (Bironaite et al, 1992) and the phenomenon
of enhanced toxicity in 2780/AD has been observed before for a
number of resistance modifying agents (Schuurhuis et al, 1990).
As colorectal tumours are known to exhibit high levels of the
P-gp protein (Fojo et al, 1987) and are intrinsically resistant to
drugs involved in MDR it could be interesting to investigate
whether a resistance modifying effect of rhein exists in human
P-gp overexpressing colon carcinomas. Based on our study in cell
lines the effect is not expected to be mediated through P-gp.
Besides P-gp, MRP1 is found in normal colonic epithelium
(Chaman et al, 1996) and colorectal tumours (Filipits et al,
1997). This drug efﬂux pump most likely protects colonic epithe-
lial cells against xenobiotics induced damage (Shen et al, 1996)
and is involved in the extrusion of several, structurally unrelated
cytotoxic drugs including anthracyclines (Paul et al, 1996). In this
study, we have demonstrated for the ﬁrst time that rhein is a
substrate for the MRP1 drug efﬂux pump. Cytotoxicity of rhein
was reduced in the MRP1-overexpressing cell line GLC4/ADR
compared to GLC4. The inﬂuence of alterations in topoisomerase
II levels on this phenomenon was ruled out by experiments show-
ing similar cytotoxicity of rhein in GLC4 compared to GLC4/
AMSA and GLC4/VM, with reduced levels of topoisomerase IIb
and IIa respectively. The degree of rhein resistance does not seem
very high. However, in the same cell line only a 4.4-fold resistance
is found for vincristine (Cole et al, 1994), a well established
MRP1-substrate of which the cytotoxicity is not affected by topoi-
somerase reduction.
Modulation experiments revealed a complete reversal of resis-
tance of the GLC4/ADR cell line to rhein by coincubation of the
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(Paul et al, 1996) and MRP1 blocker.
Apart from cytotoxicity experiments efﬂux experiments with the
ﬂuorescent MRP1 substrate CF also showed that rhein is a substrate
for MRP1. Rhein was, in a comparable concentration to MK571
(Van der Kolk et al, 1998), a blocker of CF efﬂux.
Transport function for several drugs of MRP1 is dependent on
cellular gluthatione levels (Versantvoort et al, 1995). Cellular deple-
tion of glutathione can be achieved by preincubation with BSO, a
substance that speciﬁcally inhibits gluthathione synthesis in cells
(Meister, 1991). It was previously shown that preincubation of
GLC4 and GLC4/ADR cells with 25 mM BSO for 24 h reduced
GSH levels effectively (Meijer et al, 1987). In this study we
conﬁrmed this by the increased toxicity of doxorubicin in GLC4/
ADR cells. However, no effect of BSO preincubation on rhein toxi-
city was found. Although MRP1 has repeatedly been reported either
to transport glutathione conjugates itself or to activate an endogen-
ous glutathione-conjugate pump (Mu ¨ller et al, 1994), it is not clear
whether glutathione conjugation or co-transport are always needed
for MRP1 activity (Paul et al, 1996; Broxterman et al, 1995).
Recently, it was shown that cellular glutathione depletion did not
affect MRP1-dependent extrusion of the acetoxymethylester of
calcein or free calcein either (Hollo ￿ et al, 1996). In contrast to
our study, in an in vitro study with rat hepatocytes increased rhein
cytotoxicity was found after 5 h preincubation with 0.5 mM BSO
(Bironaite and O ¨llinger, 1997). Although it can not be excluded
that the 20-fold higher BSO concentrations used in that study
compared to our study is toxic in itself for rat hepatocyte cells,
evaluation of any short-lasting (4 h) effect of 24 h BSO preincuba-
tion could not be determined in our experimental design, as the
solvability of rhein did not allow high enough concentrations to
induce cytotoxicity.
Induction of carcinomas by anthranoid laxatives have been
demonstrated in animal studies (Mori et al, 1985) and mutagenic
and genotoxic effects were described in bacterial strains (Westen-
dorf et al, 1990; Brown and Brown, 1976). Mutations occurred
predominantly in those strains sensitive to frame-shifting mutagens
(Brown and Dietrich, 1979), which suggest that anthranoids might
achieve DNA-damage probably by intercalation. In the present
study no DNA-intercalating capacity of rhein, aloe emodin or
danthron could be demonstrated in the bacterial plasmid DNA
PBR322.
Anthranoid laxatives have been shown to induce apoptosis of
colonic epithelial cells in man within 6 h after ingestion (Van
Gorkom et al, 2001). Animal studies also demonstrated increased
apoptosis 6 h after danthron administration (Walker et al, 1988).
In our in vitro study, although little apoptosis was found in the
GLC4 and GLC4/ADR cell lines rhein induced apoptosis in the
control cell lines. These different effects are more likely to be cell
type than resistance related. In the apoptosis sensitive cell line Tera
the highest apoptosis induction was found. Caco-2, a colon carci-
noma cell line which is relatively insensitive to apoptosis-induction
by doxorubicin, readily underwent apoptosis induction after 48 h
incubation with 100 mM rhein. This concentration is below the
concentration reached in the colonic lumen after therapeutic doses
of anthranoid laxatives used as a bowel preparation for diagnostic
procedures (Scho ¨rkhuber et al, 1998). Single doses of 0.15 g senno-
sides corresponding to 0.5 mmol rhein anthrone in approximately
2 litre colonic contents yield concentrations of about 250 mM.
In conclusion, this study demonstrates that rhein, the active
metabolite of sennoside laxatives, is a substrate for the MRP1 drug
efﬂux pump and is a cytotoxic agent capable of inducing apoptosis.
This cytotoxicity is neither topoisomerase II related nor a result of
DNA intercalation. The capacity to extrude the anthranoid laxative
may be important to protect the epithelium. Evaluation of colonic
MRP1 levels in chronic users of anthranoid laxatives can be of
interest. It may well be that the risk to develop colon cancer in
anthranoid laxative users is negatively related to MRP1 expression.
In addition also mutations or polymorphisms in MRP1 may play a
role.
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